DURAVYU Hits Primary Phase 2 Endpoint, Reduces Treatment Burden in DME
Both doses of DURAVYU extended the time to the first supplemental injection versus aflibercept control in the Phase 2 VERONA trial.
Both doses of DURAVYU extended the time to the first supplemental injection versus aflibercept control in the Phase 2 VERONA trial.
Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still cancer-free years later in a small early-stage trial,…
Tolve etĀ al. demonstrate that AP-2 stabilizes GRID2IP to regulate synaptic function in Purkinje cells. Loss of AP-2 disrupts synaptic connectivity, alters network activity, and impacts…
Background The impact of a healthy diet on the secondary prevention of ischemic stroke (IS) remains uncertain. Levels of low-density lipoprotein cholesterol (LDL-C) are inversely…
This communication is part of the Communications Pilot to Enhance the Medical Device Recall Program
Medical Device Reports (MDRs) about systemic symptoms or breast implant illness.
A gauge of Chinese tech shares trading in Hong Kong was poised to enter a technical bull market after DeepSeekās artificial intelligence model ignited interest…
Two senators wrote to the FDA Friday about the Hims Super Bowl ad, which they said misleads patients about compounded weight loss drugs.
Medline Integrated Arterial Catheters continuously monitor blood pressure. Excess material on the catheter hub that may detach and enter the patient.
This JAMA Viewpoint investigates the rising popularity of nicotine pouches, especially among youths, and how the US Food and Drug Administration must act quickly to…
Modern Healthcare’s Innovators Awards program recognizes leaders and organizations driving innovation that improves care, achieves measurable results and contributes to clinical and financial goals. Successful…